0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Screening for Skin Cancer FREE

Edward H. Livingston, MD
JAMA. 2016;316(4):470. doi:10.1001/jama.2016.9817.
Text Size: A A A
Published online

The US Preventive Services Task Force (USPSTF) has published updated recommendations on screening for skin cancer.

WHAT IS SKIN CANCER?

Skin that is exposed to the sun can become damaged, causing skin cells to uncontrollably divide. When this occurs in the skin’s outermost layers, it is known as squamous cell carcinoma. Basal cell carcinoma occurs when the affected cells are just below the squamous cells in the skin. The cells that make the brown pigment melanin, which gives skin its brown color, are called melanocytes, and when they become cancerous, the cancer is called melanoma. Squamous and basal cell cancers spread around the place where they start but usually do not spread to other parts of the body. Melanoma accounts for only 2% of skin cancers but spreads rapidly throughout the body and can cause death. It is best to find and remove these cancers early. It is not known if screening (deliberately looking for these cancers on a regular basis) helps detect melanoma early enough to help people.

WHAT TESTS ARE USED TO SCREEN FOR SKIN CANCER?

Because skin cancers can be seen by carefully looking at the skin, screening for skin cancer involves having a clinician carefully look at all skin surfaces trying to find cancers. Lesions that look suspicious have some or all of the following characteristics (ABCDE):

  • Asymmetrical (one half is not identical to the other)

  • Borders that are irregular, uneven, or ragged

  • Color that varies from one area to another

  • Diameter that is larger than 6 mm (larger than a pencil eraser)

  • Evolving over time

If you notice any skin lesions that have these features, show them to your physician. Previous JAMA Patient Pages on detecting skin cancer and on melanoma have more information about these cancers and pictures of what some of them look like. Any suspicious lesions should be removed, or a biopsy should be performed by having a clinician remove a piece of the abnormal skin lesion for a pathologist to look at it.

WHAT IS THE PATIENT POPULATION UNDER CONSIDERATION FOR SCREENING FOR SKIN CANCER?

The screening recommendation was made for adults who do not have any symptoms associated with skin cancer or any history of premalignant or malignant skin lesions. These screening recommendations do not apply to anyone with a suspicious skin lesion or who has a high risk of skin cancer (people who have skin cancer in their family or who have a skin cancer syndrome).

WHAT ARE THE POTENTIAL BENEFITS AND HARMS OF SCREENING FOR SKIN CANCER?

In general, finding cancers early should help people. For many skin cancers, finding and removing them early reduces the amount of skin that needs to be removed, resulting in less scarring or disfigurement. There have not been any definitive studies showing that screening for skin cancer results in helping a substantial number of people.

It is also not clear if screening for skin cancer harms anyone. Most lesions removed or biopsied because they are thought to be skin cancer are not cancer. It is not known if removing these lesions harms anyone.

HOW STRONG IS THE RECOMMENDATION TO SCREEN FOR SKIN CANCER?

There are no studies definitively showing that screening for skin cancer hurts or helps people.

BOTTOM LINE: CURRENT RECOMMENDATION FOR SCREENING FOR SKIN CANCER

The USPSTF concludes that the current evidence is insufficient (called an “I” recommendation) to assess the balance of benefits and harms of screening for skin cancer in adults.

ARTICLE INFORMATION

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

Source: US Preventive Services Task Force. Screening for skin cancer: US Preventive Services Task Force recommendation statement. JAMA. doi:10.1001/jama.2016.8465.

Topic: Preventive Medicine

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Spanish Patient Page: Pruebas de detección del cáncer de piel

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

3,546 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs